Computed radiography vendor Fuji Medical Systems USA (Hall A, #2732) will unveil its ambitious program to develop a new line of Windows NT-based PACS products called Synapse. The Stamford, CT, company believes that starting its development effort from
Computed radiography vendor Fuji Medical Systems USA (Hall A, #2732) will unveil its ambitious program to develop a new line of Windows NT-based PACS products called Synapse. The Stamford, CT, company believes that starting its development effort from scratch will enable it to incorporate a number of cutting-edge technologies into Synapse that are unavailable on older PACS products.
Two of the latest technologies are cascadable architecture and on-demand image review. Cascadable architecture is a new client-server configuration in which the archive's database management software runs on multiple hardware components distributed throughout a network. The technology is an alternative to dedicating an entire server to database management tasks, which can make expanding a PACS network more difficult, according to John Strauss, director of marketing for Fuji's new Imaging and Information Networks group.
On-demand image review provides an alternative to image auto-routing, in which images are automatically sent to specified workstations. With Fuji's on-demand software, images can be read with optimized protocols anywhere on the network, adding additional flexibility.
The first workstations in the Synapse line will be dedicated to computed radiography applications and will be shown in Fuji's RSNA booth. HI-C/QA is a quality-assurance workstation, while HI-C/NT is a CR image review workstation that will be expanded to support multimodality images. Fuji's workstations will come in 1K x 1K and 2K x 2.5K configurations, and the line will have native DICOM output.
Fuji plans to release HI-C/QA and HI-C/NT in the first quarter of 1998, with the rest of its PACS product line ready for commercial shipments by the end of next year, according to Clay Larsen, managing director of marketing.
Can Portable Dual-Energy X-Ray be a Viable Alternative to CT in the ICU?
September 13th 2024The use of a portable dual-energy X-ray detector in the ICU at one community hospital reportedly facilitated a 37.5 percent decrease in chest CT exams in comparison to the previous three months, according to research presented at the American Society of Emergency Radiology (ASER) meeting in Washington, D.C.
New Meta-Analysis Examines MRI Assessment for Treatment of Esophageal Cancer
September 12th 2024Diffusion-weighted MRI provided pooled sensitivity and specificity rates of 82 percent and 81 percent respectively for gauging patient response to concurrent chemoradiotherapy for esophageal cancer, according to new meta-analysis.
Study for Emerging PET/CT Agent Reveals ‘New Standard’ for Detecting Clear Cell Renal Cell Carcinoma
September 11th 2024Results from a multicenter phase 3 trial showed that the PET/CT imaging agent (89Zr)Zr-girentuximab had an 85.5 percent mean sensitivity rate for the diagnosis of clear cell renal cell carcinoma.
Can Radiomics and Autoencoders Enhance Real-Time Ultrasound Detection of Breast Cancer?
September 10th 2024Developed with breast ultrasound data from nearly 1,200 women, a model with mixed radiomic and autoencoder features had a 90 percent AUC for diagnosing breast cancer, according to new research.